Enliven Therapeutics

BiotechnologySeries BBoulder, USenliventherapeutics.com

Latest round

Series B

Last raised

Jan 2022

Total raised

$85M

Investors

8

About Enliven Therapeutics

Based in Colorado, US, and founded in 2019, Enliven Therapeutics, Inc. operates as a precision oncology company. Sam Kintz (CEO), Joe Lyssikatos, and Anish Patel are the co-founders of the company. In February 2022, Enliven Therapeutics, Inc. The company is a biopharmaceutical company that focuses on the discovery and development of small molecule inhibitors to help cancer patients by combining clinically validated biological targets with industry-leading chemistry to address the limitations of existing therapies, providing the healthcare sector with new techniques, and assisting patients in extending and improving their lives.

Who invested in Enliven Therapeutics

8 investors across 3 rounds

See all investors in Enliven Therapeutics

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series B

    Jan 19, 2022

    Amount

    $85M

    Investors

    Locked

  2. Series A

    Dec 7, 2020

    Amount

    Undisclosed

    Investors

    Locked

  3. Seed

    Jun 1, 2019

    Amount

    Undisclosed

    Investors

    Locked

Questions about Enliven Therapeutics

Who invested in Enliven Therapeutics?

Enliven Therapeutics has 8 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Enliven Therapeutics raised?

Enliven Therapeutics has raised 3 venture rounds. Sign up free to see how much each round raised and the total.

When did Enliven Therapeutics last raise money?

Enliven Therapeutics's most recent round on record is a Series B, in Jan 2022.

What does Enliven Therapeutics do?

Based in Colorado, US, and founded in 2019, Enliven Therapeutics, Inc.

Where is Enliven Therapeutics headquartered?

Enliven Therapeutics is headquartered in Boulder, US.

Which VCs invest in companies like Enliven Therapeutics?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Enliven Therapeutics's stage. Their profiles are linked below.

Raising like Enliven Therapeutics? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.